Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 256

1.

Opportunities and obstacles in developing a vaccine for Entamoeba histolytica.

Miller-Sims VC, Petri WA Jr.

Curr Opin Immunol. 2002 Oct;14(5):549-52. Review.

PMID:
12183151
2.

The future for vaccine development against Entamoeba histolytica.

Quach J, St-Pierre J, Chadee K.

Hum Vaccin Immunother. 2014;10(6):1514-21. doi: 10.4161/hv.27796. Epub 2014 Feb 6. Review.

3.

Entamoeba histolytica: from adherence to enteropathy.

Ravdin JI.

J Infect Dis. 1989 Mar;159(3):420-9. Review.

PMID:
2536786
4.

Immunogenicity of the recombinant serine rich Entamoeba histolytica protein (SREHP) amebiasis vaccine in the African green monkey.

Stanley SL Jr, Blanchard JL, Johnson N, Foster L, Kunz-Jenkins C, Zhang T, Tian K, Cogswell FB.

Vaccine. 1995 Jul;13(10):947-51.

PMID:
7483769
5.
6.

Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess.

Min X, Feng M, Guan Y, Man S, Fu Y, Cheng X, Tachibana H.

PLoS Negl Trop Dis. 2016 Jan 29;10(1):e0004419. doi: 10.1371/journal.pntd.0004419. eCollection 2016 Jan.

7.

Immunization with the Entamoeba histolytica surface metalloprotease EhMSP-1 protects hamsters from amebic liver abscess.

Roncolato EC, Teixeira JE, Barbosa JE, Zambelli Ramalho LN, Huston CD.

Infect Immun. 2015 Feb;83(2):713-20. doi: 10.1128/IAI.02490-14. Epub 2014 Dec 1.

9.

Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin.

Houpt E, Barroso L, Lockhart L, Wright R, Cramer C, Lyerly D, Petri WA.

Vaccine. 2004 Jan 26;22(5-6):611-7.

PMID:
14741152
11.

Prospect for an Entamoeba histolytica Gal-lectin-based vaccine.

Gaucher D, Chadee K.

Parasite Immunol. 2003 Feb;25(2):55-8. Review.

12.

Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.).

Abd Alla MD, Wolf R, White GL, Kosanke SD, Cary D, Verweij JJ, Zhang MJ, Ravdin JI.

Vaccine. 2012 Apr 26;30(20):3068-75. doi: 10.1016/j.vaccine.2012.02.066. Epub 2012 Mar 8.

PMID:
22406457
13.
14.

Vaccines for amoebiasis: barriers and opportunities.

Stanley SL Jr.

Parasitology. 2006;133 Suppl:S81-6. Review.

PMID:
17274850
15.

Progress towards development of a vaccine for amebiasis.

Stanley SL Jr.

Clin Microbiol Rev. 1997 Oct;10(4):637-49. Review.

17.

Role of mucosal secretory immunity in the development of an amebiasis vaccine.

Ravdin JI, Kelsall BL.

Am J Trop Med Hyg. 1994;50(5 Suppl):36-41. Review.

PMID:
8203722
18.

Seroepidemiology of Entamoeba histolytica in a slum in northeastern Brazil.

Braga LL, Lima AA, Sears CL, Newman RD, Wuhib T, Paiva CA, Guerrant RL, Mann BJ.

Am J Trop Med Hyg. 1996 Dec;55(6):693-7.

PMID:
9025700
19.

Host-pathogen interaction in amebiasis and progress in vaccine development.

Huston CD, Petri WA Jr.

Eur J Clin Microbiol Infect Dis. 1998 Sep;17(9):601-14. Review.

PMID:
9832261
20.

Supplemental Content

Support Center